New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...
At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...
Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.
Groundbreaking research presented at the San Antonio Breast Cancer Symposium suggests thousands of women with early-stage ...
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...
Over half of breast cancer survivors (57.2%) report oncologist-led care more than 5 years posttreatment, while only 22.4% ...
A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the ...
The Barbara Cares Foundation, a Fort Worth-based nonprofit, has $10,000 of funding to give out by the end of the year.